Duxocin-50 Doxorubicin Hydrochloride Injection IP 50 mg

Get a Price/Quote

MOQ : 100 Pieces

Duxocin-50 Doxorubicin Hydrochloride Injection IP 50 mg Specification

Origin of Medicine
India

Life Span
Refer to packaging for expiry date

Pacakaging (Quantity Per Box)
1 vial

Salt Composition
Doxorubicin Hydrochloride

Dosage Form
Injection

Packaging Type
Vial

Indication
Used for the treatment of a variety of cancers, including breast cancer, bladder cancer, lymphoma, and others

Drug Type
Prescription only

Ingredients
Doxorubicin Hydrochloride

Physical Form
Injection

Function

Recommended For
Adults and children with cancer as prescribed by a physician

Dosage
As prescribed by the oncologist; varies based on treatment protocol

Dosage Guidelines
Administered intravenously; dose and schedule as directed by physician

Quantity
50 mg

Storage Instructions
Store below 25C; protect from light

Reconstitution
To be reconstituted as per prescribing guidelines/instructions provided with the vial

Contraindications
Contraindicated in patients with known hypersensitivity to doxorubicin or its excipients; patients with severe myocardial insufficiency

Appearance
Sterile, lyophilized powder for injection

Strength
50 mg/vial

Prescription Required
Yes

Manufactured By
Adley Formulations

Therapeutic Class
Anticancer / Chemotherapeutic agent

Schedule
Schedule H drug (India); to be sold by retail on the prescription of a Registered Medical Practitioner only

Route of Administration
Intravenous

International Availability
Available in Canada, EU, UK, USA, Australia

Side Effects
Contact healthcare provider for side effects; may include nausea, vomiting, bone marrow suppression, alopecia, and cardiotoxicity

Duxocin-50 Doxorubicin Hydrochloride Injection IP 50 mg Trade Information

Minimum Order Quantity
100 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Pieces Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Duxocin-50 Doxorubicin Hydrochloride Injection IP 50 mg

Get It Now - introducing the New and Exclusive Duxocin-50 Doxorubicin Hydrochloride Injection IP 50 mg, expertly crafted by Adley Formulations. This laureate anticancer agent is a glorious addition to your treatment arsenal, renowned for its potent antineoplastic properties. Engineered for intravenous use, Duxocin-50 is the virtuoso choice for chemotherapy in both adult and pediatric cancer patients, including those battling breast cancer, lymphoma, and more. Available internationally, this sterile, lyophilized powder is reserved for prescription-only protocols, promising precision, purity, and clinical excellence. Store below 25C and administer under medical supervision. Get your exclusive vial now!

Precise Application & Prime Usage

Duxocin-50 Doxorubicin Hydrochloride Injection IP 50 mg is administered intravenously by qualified healthcare professionals. Recommended for adults and children diagnosed with cancer, it is used for treating a wide range of malignancies, including breast and bladder cancers, and lymphoma. Its use type is strictly prescription-based, ensuring medical oversight and optimized patient safety. Treatment protocols are tailored by the physician, guaranteeing the individualized care each patient deserves.

Swift Delivery & Nationwide Reach

Shipped with care and speed, Duxocin-50 is available across the main domestic markets in India and is internationally accessible. Our trusted goods transport partners handle each vial to ensure timely arrival at healthcare facilities. For sampling, we provide a transparent sample policy upon request. Rely on our efficient logistics for your life-saving medicine-each order is processed to maintain quality from dispatch to arrival.

FAQ's of Duxocin-50 Doxorubicin Hydrochloride Injection IP 50 mg:

Q: How is Duxocin-50 Doxorubicin Hydrochloride Injection administered?

A: Duxocin-50 is administered intravenously by a healthcare professional according to the treatment protocol prescribed by your oncologist.

Q: What cancers is Duxocin-50 used to treat?

A: Duxocin-50 is indicated for several cancers, including breast cancer, bladder cancer, lymphoma, and other malignancies as directed by your physician.

Q: When should Duxocin-50 not be used?

A: This medication should not be used in patients with known hypersensitivity to doxorubicin or its components, or those with severe myocardial insufficiency.

Q: Where is Duxocin-50 available?

A: Duxocin-50 is internationally available in countries such as Canada, the EU, UK, USA, and Australia, as well as throughout India.

Q: What are the usage and dosage guidelines for Duxocin-50?

A: Dosage and usage are determined by the treating oncologist based on the patient's treatment protocol and must be strictly followed as prescribed.

Q: What are the potential benefits of using Duxocin-50?

A: Duxocin-50 offers significant therapeutic benefits as a powerful chemotherapeutic agent, helping to manage and treat various types of cancer under professional supervision.

Tell us about your requirement